CDXS
Codexis Inc
NASDAQ: CDXS · HEALTHCARE · BIOTECHNOLOGY
$2.82
+0.36% today
Updated 2026-04-30
Market cap
$238.08M
P/E ratio
—
P/S ratio
3.38x
EPS (TTM)
$-0.50
Dividend yield
—
52W range
$1 – $4
Volume
2.6M
Codexis Inc (CDXS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-62.50%
Operating margin
35.90%
ROE
-74.90%
ROA
-16.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $12.13M | $-18.67M | 85.11% | -155.16% | -153.96% |
| 2007 | $25.33M | $-38.98M | 67.16% | -151.36% | -153.86% |
| 2008 | $50.48M | $-45.13M | 73.87% | -87.11% | -89.40% |
| 2009 | $82.91M | $-20.29M | 79.88% | -22.15% | -24.47% |
| 2010 | $107.10M | $-8.54M | 73.87% | -6.65% | -7.97% |
| 2011 | $123.86M | $-16.55M | 66.27% | -12.84% | -13.36% |
| 2012 | $88.30M | $-30.86M | 65.29% | -34.56% | -34.95% |
| 2013 | $31.92M | $-41.30M | 54.41% | -128.90% | -129.39% |
| 2014 | $35.31M | $-19.07M | 72.45% | -54.13% | -54.01% |
| 2015 | $41.80M | $-7.58M | 84.25% | -18.59% | -18.13% |
| 2016 | $48.84M | $-8.56M | 80.03% | -17.54% | -17.52% |
| 2017 | $50.02M | $-23.00M | 71.36% | -45.92% | -45.97% |
| 2018 | $60.59M | $-10.88M | 79.17% | -18.64% | -17.95% |
| 2019 | $68.46M | $-11.94M | 77.17% | -18.33% | -17.43% |
| 2020 | $69.06M | $-24.01M | 80.10% | -34.64% | -34.77% |
| 2021 | $104.75M | $-21.28M | 78.80% | -21.67% | -20.31% |
| 2022 | $138.59M | $-33.59M | 72.56% | -25.17% | -24.24% |
| 2023 | $70.14M | $-76.24M | 81.74% | -97.04% | -108.69% |
| 2024 | $59.34M | $-65.28M | 72.55% | -98.61% | -109.99% |
| 2025 | $70.39M | $-43.97M | 79.49% | -54.46% | -62.47% |